secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENZO BIOCHEM INC (—)
CIK:        0000316253
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001213900-24-102169
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Enzo Biochem appoints Jon Couchman to Board of Directors and three committees
-----------------------------------------------------------------------------

- Jon Couchman appointed to Enzo Biochem Board effective November 22, 2024, and to Audit, Compensation, and Nominating/Governance Committees.
- Couchman is Managing Member of Couchman Management LLC, holds CFA; previously Chairman/CEO/CFO of Xstelos, Myrexis, Affymax.
- Compensation follows standard non-employee director plan as described in the 2023 proxy statement.
- No arrangements or understandings with any other person regarding selection; no reportable related-party transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/316253/000121390024102169/0001213900-24-102169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/316253/000121390024102169/ea0222393-8k_enzobio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-102169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer